Josh Slatko interviewed Jane for an article in PharmaLive on a final rule from the Centers for Medicare and Medicaid Services that will require direct-to-consumer TV ads for prescription pharmaceuticals covered by Medicare or Medicaid to include the list price. A snippet of Jane’s response: “HHS’ price disclosure plans don’t speak to personalized health or healthcare costs, given the fact that a retail list price for a prescription drug is not what the health consumer actually pays.“
Jane quoted on the prospects prescription drug cost transparency in PharmaLive
By Jane Sarasohn-Kahn on 27 June 2019 in
As you may know, I have been splitting work- and living-time between the U.S. and the E.U., most recently living in and working from Brussels. In the month of September 2024, I'll be splitting time between London and other parts of the U.K., Spain and Italy where I'll be working with clients on consumer health, self-care and home care focused on food-as-medicine, digital health, business and scenario planning for the future...
Thank you, Max Mamoyco of Nozomi, for including the Health Populi blog as one of 20 must-follows in #digitalhealth.
I was interviewed live on BNN Bloomberg (Canada) on the market for GLP-1 drugs for weight loss and their impact on both the health care system and consumer goods and services -- notably, food, nutrition, retail health, gyms, and other sectors.